Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

High serum urate protects against dementia in women

14 Jun 2019

Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.

Researchers followed 1,447 women (mean age, 47.4±6.2 years) for a mean of 33.1 years and monitored for the development of late-life dementia. Serum urate concentrations were measured through standard routine clinical laboratory testing upon enrolment into the study at 1968–1969.

Mean serum urate concentration at baseline was 233.8±75.0 µmol/L, which rose slightly to 271.3±72.7 µmol/L during the follow-up examination between 1992 and 1994. The mean change in serum urate was 45.3±77.6 µmol/L.

A total of 320 participants developed dementia: 151 had Alzheimer’s disease without cerebrovascular disease, 52 had pure vascular dementia, 91 developed mixed dementia and 26 developed dementia of other types. The mean age at onset was 79.9±7.9 years, while the average time between serum urate measurement and dementia onset was 15.8±10.4 years.

Age-adjusted competing risk Cox proportional hazard analysis showed that higher serum urate was associated with a reduced risk of developing dementia (adjusted hazard ratio [HR] per standard deviation value of 76.5 µmol/L, 0.81, 95 percent CI, 0.72–0.91).

The same remained true for Alzheimer’s disease (adjusted HR, 0.78, 0.66–0.91) and vascular dementia (adjusted HR, 0.66, 0.47–0.94). Adjusting for confounders, such as education, body mass index, alcohol and smoking consumption patterns, and blood biochemistry did not meaningfully alter the findings.

If confirmed in future studies with larger study populations, the present findings may have important implications in treatment decisions for hyperuricaemia in patients with gout, with respect to potential dementia risk, said researchers.

Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.